"We are delighted to introduce TriPollar technology to the Brazilian market. Brazil's aesthetic market is one of the fastest growing markets in the world and both aesthetic professionals and patients are constantly seeking the latest anti aging technologies. TriPollar based products have proven to be effective in treating a wide variety of aesthetic needs and we are excited to be offering TriPollar based solutions in Brazil" said HV Com's CEO, Mr. Newton Martins.
Pollogen's CEO, Dr. Zion Azar stated: "The Brazilian market is a significant milestone for Pollogen and we are delighted to have received the ANVISA approval. Pollogen's global presence now covers over 60 countries and we are delighted to be in the forefront of aesthetic solutions that offer a non-surgical alternative that yields both immediate and long term anti-aging results."
Pollogen Ltd. develops, manufactures and markets professional medical aesthetic devices, powered by the TriPollar 3rd generation Radio Frequency (RF) technology. Invented and perfected by Pollogen, proprietary TriPollar technology powers a full line of clinically-proven, non-invasive and non-surgical treatment platforms for wrinkles, cellulite, circumference reduction and skin tightening. The flagship aesthetic devices, apollo™ and regen™ offer customers clinically-proven, safe and effective anti-aging beauty treatments that deliver immedi
Copyright©2009 Vocus, Inc.
All rights reserved